Emiko Takai

690 total citations
17 papers, 587 citations indexed

About

Emiko Takai is a scholar working on Epidemiology, Hepatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Emiko Takai has authored 17 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 9 papers in Hepatology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Emiko Takai's work include Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Emiko Takai is often cited by papers focused on Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Emiko Takai collaborates with scholars based in Japan, Greece and Tunisia. Emiko Takai's co-authors include Fumio Tsuda, Y. Miyakawa, Hiroyuki Ohnuma, T. Nakamura, Yuzo Miyakawa, M Mayumi, Yoshito Itoh, K Kitajima, Shunji Mishiro and Makoto Mayumi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Immunology.

In The Last Decade

Emiko Takai

16 papers receiving 553 citations

Peers

Countries citing papers authored by Emiko Takai

Since Specialization

Citations

This map shows the geographic impact of Emiko Takai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emiko Takai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emiko Takai more than expected).

Fields of papers citing papers by Emiko Takai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emiko Takai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emiko Takai. The network helps show where Emiko Takai may publish in the future.

Co-authorship network of co-authors of Emiko Takai

This figure shows the co-authorship network connecting the top 25 collaborators of Emiko Takai. A scholar is included among the top collaborators of Emiko Takai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emiko Takai. Emiko Takai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Asymptomatic Pyuria in Diabetic Women. 2001 ·Journal of Nippon Medical School ·Hiroshi Nakano, Kenzo Oba, (unknown), Motoshi Ouchi, Naoko Yamashita, (unknown), Emiko Takai, (unknown), Noriaki Matsumura, (unknown), Tatsuya Suzuki	10
2	Hepatitis B surface antigen particles of subtypes adw and adr, and compound subtype (adwr) in symptom‐free carriers in Japan 1992 ·Journal of Medical Virology ·Hiroshi Kanagawa, Emiko Takai, Fumio Tsuda, Atsuhiko Machida, Mineo Kojima, (unknown), Takeshi Tanaka, Hiroaki Okamoto, (unknown), Makoto Mayumi	11
3	Synthetic oligopeptides bearing a common or subtypic determinant of hepatitis B surface antigen. 1990 ·The Journal of Immunology ·Hiroyuki Ohnuma, Emiko Takai, A Machida, Fumio Tsuda, Hiroaki Okamoto, Toshinori Tanaka, Maiko Naito, Eisuke Munekata, K. Miki, Y. Miyakawa, (unknown)	17
4	Antibodies to translation products of the pre-S1 and pre-S2 regions of the envelope gene of hepatitis B virus in fulminant hepatitis B 1988 ·Hepatology ·I Ise, Fumio Tsuda, (unknown), Atsuhiko Machida, Emiko Takai, Hideaki Miyamoto, Yoshihiro Akahane, Yuzo Miyakawa, Makoto Mayumi	12
5	A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. 1986 ·Proceedings of the National Academy of Sciences ·Yoshito Itoh, Emiko Takai, Hiroyuki Ohnuma, K Kitajima, Fumio Tsuda, (unknown), Shunji Mishiro, T. Nakamura, Y. Miyakawa, M Mayumi	213
6	PRE-S2 ANTIBODIES IN HEPATITIS B 1986 ·The Lancet ·A. Albertí, Patrizia Pontisso, (unknown), (unknown), I Ise, Fumio Tsuda, Emiko Takai, Atsuhiko Machida, Yuzo Miyakawa, Makoto Mayumi, (unknown), (unknown), (unknown)	9
7	Polypeptides coded for by the region pre-S and gene S of hepatitis B virus DNA with the receptor for polymerized human serum albumin: expression on hepatitis B particles produced in the HBeAg or anti-HBe phase of hepatitis B virus infection. 1986 ·The Journal of Immunology ·Kazuo Takahashi, (unknown), Hiroyuki Ohnuma, A Machida, Emiko Takai, Fumio Tsuda, Hideaki Miyamoto, Toru Tanaka, (unknown), Oda K, (unknown), (unknown)	42
8	Translation products of pre-S(1), pre-S(2) regions and the S gene of hepatitis B virus: susceptibility of their antigenic activities to treatment with heat, urea, formalin or pepsin. 1986 ·PubMed ·Hiroyuki Ohnuma, A Machida, Emiko Takai, Fumio Tsuda, Hideaki Miyamoto, Toru Tanaka, Oda K, Sadakazu Usuda, T. Nakamura, Y. Miyakawa	3
9	Antibody to the receptor for polymerized human serum albumin in acute and persistent infection with hepatitis B virus 1986 ·Hepatology ·Hiroaki Okamoto, Sadakazu Usuda, Mitsunobu Imai, Katsumi Tachibana, Eiji Tanaka, (unknown), (unknown), Emiko Takai, Fumio Tsuda, Tetsuo Nakamura, Yuzo Miyakawa, Makoto Mayumi	36
10	A solid-phase enzyme immunoassay for the determination of IgM and IgG antibodies against translation products of pre-S1 and pre-S2 regions of hepatitis B virus 1986 ·Journal of Immunological Methods ·Emiko Takai, Atsuhiko Machida, (unknown), Hideaki Miyamoto, Takeshi Tanaka, Kiyoshi Baba, Fumio Tsuda, S Usuda, Tetsuo Nakamura, Yuzo Miyakawa, Makoto Mayumi	38
11	Natural seroconversion of HBe antigen to anti-HBe in HBs antigen carrier children - From the difference of the modes of HBV transmission. 1985 ·Kanzo ·Mineo Kojima, Masanori Yasuda, Hiroshi Tanaka, (unknown), Masaru Shimizu, Yoshiyata TAKAHASHI, (unknown), Fumio Tsuda, Emiko Takai	6
12	Studies of short-term prednisolone therapy in children with HBeAg positive chronic type B hepatitis. 1985 ·Kanzo ·Masanori Yasuda, Hiroshi Tanaka, (unknown), Masaru Shimizu, Yoshiyata TAKAHASHI, (unknown), Fumio Tsuda, Emiko Takai, Mineo Kojima	0
13	A case of chronic active hepatitis type B with severe liver dysfunction induced by steroid withdrawal therapy - Improved by remedication of corticosteroid. 1985 ·Kanzo ·Masaru Shimizu, (unknown), Hajime Tokita, (unknown), (unknown), (unknown), Kazunori Watanabe, (unknown), (unknown), Yoshiyata TAKAHASHI, Mineo Kojima, Emiko Takai, (unknown)	3
14	Factors Influencing Postexposure Immunprophylaxis of Hepatitis B Virus Infection With Hepatitis B Immune Globulin 1985 ·Gastroenterology ·Kazuo Masuko, Takehiro Mitsui, Keiko Iwano, Chikao Yamazaki, (unknown), Kiyoshi Baba, Emiko Takai, Fumio Tsuda, T. Nakamura, Y. Miyakawa, M Mayumi	19
15	Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection 1984 ·Gastroenterology ·Fumio Tsuda, (unknown), Emiko Takai, Yoshihiro Akahane, Seiichi Furuta, Yuzo Miyakawa, Makoto Mayumi	42
16	Low C3B receptor reactivity on erythrocytes from patients with systemic lupus erythematosus detected by immune adherence hemagglutination and radioimmunoassays with monoclonal antibody 1984 ·Arthritis & Rheumatism ·Seiji Minota, Chihiro Terai, Yoshihisa Nojima, (unknown), Emiko Takai, Yuzo Miyakawa, Fumimaro Takaku	57
17	Immunoglobulin M antibody against hepatitis B core antigen for the diagnosis of fulminant type B hepatitis 1983 ·Gastroenterology ·Masahito Shimizu, (unknown), (unknown), (unknown), (unknown), Masaaki KAMETANI, Fumio Tsuda, Emiko Takai, Y. Miyakawa, Makoto Mayumi	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact